# Humacyte, Inc. (HUMAW) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_c34fad37d6bfaf5d8a49 · retrieved 2026-08-11T15:50:51.239Z

## Overview
Humacyte, Inc. is a biological products company (SIC 2836) that develops engineered human tissues and organs for transplantation and therapeutic applications.

On July 31, 2026, Humacyte, Inc. received notification from Nasdaq that its common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Select Market for 30 consecutive business days ended July 30, 2026. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted an initial 180-calendar-day cure period, expiring January 27, 2027, to regain compliance. To regain compliance, the closing bid price must reach $1.00 per share or higher for a minimum of 10 consecutive business days before the deadline. The notice has no immediate effect on the Company's listing or business operations.

## Terms
- Counterparty: The Nasdaq Stock Market LLC · Price/share: $1

## Key dates
- Announced 2026-07-31 · Expiry 2027-01-27

## Timeline
- 2026-07-31 · 8-K (0001104659-26-089281): 8-K - Humacyte, Inc. — *Humacyte, Inc. is a biological products company (SIC 2836) that develops engineered human tissues and organs for transplantation and therapeutic applications.* On July 31, 2026, Humacyte, Inc. received notification from Nasdaq that its common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Select Market for 30 consecutive business days ended July 30, 2026. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted an initial 180-calendar-day cure period, expiring January 27, 2027, to regain compliance. To regain compliance, the closing bid price must reach $1.00 per share or higher for a minimum of 10 consecutive business days before the deadline. The notice has no immediate effect on the Company's listing or business operations.
  https://www.sec.gov/Archives/edgar/data/1818382/0001104659-26-089281.txt

## Citations
- 0001104659-26-089281 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926089281